The life cycle of maize is that of a typical angiosperm.

Influence of Chronic Angiotensin II Infusion on Kidney Function and Intrarenal Angiotensin II Levels in Rats.

慢性乙型血管张力素灌注对老鼠肾功能及肾内乙型血管张力素浓度的影响.

The renin-angiotensin-aldosterone system plays an important role in regulating the circadian rhythms of blood pressure.

肾素 - 血管紧张素 - 醛固酮系统在血压昼夜节律的调节中起着关键作用.

We looked at two doses which also provide incremental inhibition of the renin-angiotensin system.

两种剂量的肾素 - 血管紧张素系统抑制剂同样有递增抑制作用.

It up-stimulate the cascade of eents leading to angiotensin II formation.

而我们知道肾素是可以正向刺激一系列的反应从而导致血管紧张素II的形成的.

Renin angiotensin aldosterone ( RAA ) system was highly activated, while the blood pressure maintained normal.

肾素血管紧张素醛固酮 ( reninangiotensinaldosterone, RAA ) 系统活性明显升高.

Use of renin-angiotensin system blockers improved minimally, as did blood pressure control.

运用肾素 - 血管紧张素系统阻断剂组改善最小, 和血压对照组一样.

Angiotensin receptor ( ATR ) mRNA expression of VSMC was measured by RT PCR.

RTPCR检测VSMC血管紧张素受体 ( ATR ) mRNA表达.

But the renin-angiotensin-aldosterone system had a very active, mainly hyperactivating, response.

肾素 - 血管紧张素 - 醛固酮系统反应活跃, 一般以偏高居多.

Definitive determination of the benefit of angiotensin-converting angiotensin-receptor blockade.

而血管紧张素转化酶抑制剂疗法获益的确切结果则需要像血管紧张素受体拮抗剂一样的确定性临床试验研究.

In the renin-angiotensin-aldosterone system, the juxtaglomerular apparatus helps regulate volume and pressure.

在肾素 - 血管紧张素 - 醛固酮系统中, 肾小球旁体帮助调节血容量和压力.

Background-Angiotensin-converting enzyme inhibitor therapy improves clinical outcome and ventricular function in adults with heart failure.

血管紧张素转换酶抑制剂治疗成年人心衰能够改善患者的临床表现和心室功能.

Isolation and Purification of Angiotensin Converting Enzyme InhibitoryPeptides by High Performance Liquid Chromatography.

高效液相色谱分离纯化血管紧张素转换酶活性抑制肽.

ACE ( angiotensin-converting enzyme ) inhibitors help to lower blood pressure and reduce strain on your heart.

血管紧缩素转换 酶 抑制剂.有助于降低血压并降低心脏的负担.

Objective To evaluate the pharmaceutical effect of angiotensin-converting enzyme inhibitor ( ACEI ) captopril on ischemic myocardium.

目的评价血管紧张素转换酶抑制剂 ( ACEI ) 卡托普利对缺血心肌的药理作用.

Objective To study the correlation between the angiotensin converting enzyme ( ACE ) gene polymorphism and cerebral hemorrhage.

目的探讨血管紧张素转换酶 ( ACE ) 基因多态性和脑出血发病的关系.

Objective: To invesgate the correlation between Angiotensin converting enzyme ( ACE ) gene polymorphism and Henoch-Schonlein purpura nephritis ( HSPN ) in children.

目的: 探讨血管紧张素转换酶 ( ACE ) 基因多态性与儿童紫癜性肾炎 ( HSPN ) 的关系.

Angiotensin-converting enzyme inhibitors might prevent arterial stenosis and atherosclerosis development after stent implantation.

血管紧张素转换酶抑制剂对支架置入后血管内膜的增殖具有抑制作用.

Angiotensin converting enzyme gene ACE is considered to be related to cardiovascular endurance performance.

血管张力素转化酶基因被认为与心血管耐力表现有关.

Angiotensin-converting enzyme 2 is the rate-limiting enzyme of Ang ( 1-7 ).

血管紧张素转换酶2是Ang ( 1-7 ) 的限速酶.

AIM: Cilazapril is the third generation of angiotensin converting enzyme inhibitor.

西拉普利属第3代血管紧张肽转换酶抑制药.